Brief: Rubius Therapeutics Q3 Loss Per Share $0.42
13/11/2018 13:01
Nov 13 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS REPORTS THIRD QUARTER 2018 FINANCIAL
RESULTS
AND OPERATIONAL PROGRESS
* Q3 LOSS PER SHARE $0.42
* Q3 EARNINGS PER SHARE VIEW $-0.36 -- THOMSON REUTERS
I/B/E/S
Source text for Eikon: ID:nGNXDG1G0
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft